Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro
Restricted accessResearch articleFirst published online July, 1999
Anti-endothelial cell IgG fractions from systemic lupus erythematosus patients bind to human endothelial cells and induce a pro-adhesive and a pro-infiammatory phenotype in vitro
Affinity purified immunoglobulin G (IgG) fractions from systemic lupus erythematosus (SLE) patients positive for anti-endothelial cell antibodies (AECA) bind human umbilical vein endothelial cell (HUVEC) monolayers. In vitro incubation of serial protein concentrations of SLE AECA IgG induces a dose-dependent endothelial activation: i) increase of functional adhesion of the monocytic cell line U937; ii) upregulation of E-Selectin, ICAM-1, VCAM-1 expression evaluated by a cell solid-phase enzyme linked immunoassay; and iii) increased secretion of interleukin (IL)-6 in the culture supernatants. Control experiments carried out with HUVEC monolayers incubated with IgG fractions from normal healthy controls or from AECA negative SLE sera do not affect at all endothelial adhesion molecule expression or pro-inflammatory cytokine secretion. The AECA IgG effects are not related to both anti-phospholipid or anti-DNA activities.
Taken together the findings suggest that these autoantibodies might be important in recruiting and in activating mononuclear leukocytes responsible for vessel wall infiltration and raise the possibility that AECA might display a pathogenic role in SLE vessel damage.
Cines DB , Lyss AP , Reeber M et al. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus . J Clin Invest1984; 73: 611–625 .
2.
Le Roux G , Wautier MP , Guillevin L , Wautier JL . IgG binding to endothelial cells in systemic lupus erythematosus . Thromb Haemost1986; 56: 144–146 .
3.
Hashemi S , Smith CD , Izaguite CA . Antiendothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay . J Lab Clin Med.1987; 109: 434–440 .
4.
Rosenbaum J , Pottinger BE , Woo P et al. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases . Clin Exp Immunol. 1988; 72: 450–456 .
5.
Vismara A , Meroni PL , Tincani A et al. Antiphospholipid antibodies and endothelial cells . Clin Exp Immunol1988; 74: 247–253 .
6.
Brasile L , Kremer JM , Clarke JL , Cerilli J . Identification of an autoantibody to vascular endothelial cell-specific antigens in patients with systemic vasculitis . Am J Med1989; 87: 74–80 .
7.
Quadros NP , Roberts-Thompson PJ , Gallus AS . IgG and IgM antiendothelial cell antibodies in patients with collagen-vascular disorders . Rheum Int1990; 10: 113–119 .
8.
D'Cruz DP , Houssiau FA , Ramirez G et al. Antibodies to endothelial cells in systemic lupus erythematosus: a potential marker for nephritis and vasculitis . Clin Exp Immunol. 1991; 85: 254–261 .
9.
Perry GJ , Elston T , Khouri NA et al. Antiendothelial cell antibodies in lupus: correlations with renal injury and circulating markers of endothelial damage . Quarterly J Med1993; 86: 727–734 .
10.
Del Papa N , Conforti G , Gambini D et al. Characterization of the endothelial surface proteins recognized by anti-endothelial antibodies in primary and secondary autoimmune vasculitis . Clin. Immunol Immunopath1994; 70: 211–216 .
11.
Meroni PL , D'Cruz D , Khamastha MA , Hughes GRV . Antiendothelial cell antibodies: for scientist or for clinicians too?Clin Exp Immunol1996; 104: 199–202 .
12.
Chan EM , Chenk IHP . Prospective study of antiendothelial cell antibodies in patients with systemic lupus erythematosus . Clin Immunol Immunopath1996; 78: 41–46 .
13.
Navarro M , Cervera R , Font J et al. Antiendothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance . Lupus1997; 6: 521–526 .
14.
Van der Zee , Siegert CEH , De Vreede TA et al. Characterization of anti-endothelial antibodies in systemic lupus erythematosus (SLE) . Clin Exp Immunol. 1991; 84: 238–244 .
15.
Li JS , Liu MF , Lei HY . Characterization of antiendothelial cell antibodies in the patients with systemic lupus erythematosus: a potential marker for disease activity . Clin Immunol Immunopath1996; 79: 211–216 .
16.
Chan TM , Yu PM , Tsang KLC , Cheng IKP . Endothelial cell binding by human polyclonal anti-DNA antibodies: relationship to disease activity and endothelial functional alterations . Clin Exp Immunol1995; 100: 506–513 .
17.
Hill MB , Phipps JL , Milford-Ward A et al. Further characterization of antiendothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting . Br J Rheumatol1996; 35: 1231–1238 .
18.
Del Papa N , Guidali L , Spatola L et al. Relationship between anti-phospholipid and anti-endothelial antibodies III: b2-glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules . Clin Exp Rheumatol1995; 13: 179–186 .
19.
Penning CA , French MA , Rowell NR , Hughes PJ . Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic lupus erythematosus . J Clin Lab Immunol1985; 17: 125–130 .
20.
Del Papa N , Guidali L , Sala A et al. Endothelial cell as target for antiphospholipid antibodies . Arthritis Rheum1997; 40: 551–561 .
21.
Del Papa N , Guidali L , Sironi M et al. Antiendothelial IgG antibodies from Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion . Arthritis Rheum1996; 39: 758–766 .
22.
Carvalho D , Savage COS , Black CM , Pearson JD . IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro . J Clin Invest1996; 97: 111–119 .
23.
Levy Y , Gilburd B , George J et al. Characterization of murine monoclonal anti-endothelial cell antibodies (AECA) produced by idiotypic manipulation with human AECA . Intern Immunol1998; 10: 861–868 .
24.
Tan EN , Cohen AS , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum1982; 25: 1271–1277 .
25.
Bombardier C , Gladman DD , Urowitz MB et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE . Arthritis Rheum1992; 35: 630–640 .
26.
Whiteside TL , Dixon JA . Clinical usefulness of the Crithidia lucilae test for antibodies to native DNA . Am J Clin Pathol1979; 72: 829–835 .
27.
Ter Borg EJ , Horst G , Hummel EJ et al. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus: a long-term prospective study . Arthritis Rheum1990; 33: 634–643 .
28.
Tincani A , Meroni PL , Brucato A et al. Antiphospholipid and antimitochondrial type M5 antibodies in SLE . Clin Exp Rheumatol1985; 3321–326 .
29.
Balestrieri G , Tincani A , Spatola L et al. Anti-b2 glycoprotein I antibodies: a marker of anti-phospholipid syndrome . Lupus1995; 4: 122–130 .
30.
Del Papa N , Raschi E , Catelli L et al. Endothelial cells as a target for antiphospholipid antibodies: role of anti-b2-glycoprotein I antibodies . Am J Reproduct Immunol1997; 38: 212–217 .
31.
Kapahi P , Mason JC , Lebranchu Y et al. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus . Clin Exp Immunol1993; 92: 412–418 .
32.
Belmont HM , Buyon J , Giorno R , Abramson S . Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus . Arthritis Rheum1994; 3: 376–383 .
33.
Carson CW , Beall LD , Hunder GG et al. Serum E-selectin is increased in vasculitis, scleroderema, and systemic lupus erythematosus . J Rheumatol1993; 20: 809–814 .
34.
Gearing AJH , Hemingway I , Pigott R et al. Soluble forms of vascular adhesion molecules, E-selectin, ICAM-I and VCAM-I: pathological significance . Ann N Y Acad Sci1992; 667: 324–331 .
35.
Carlos TM , Harlan JM . Leukocyte-endothelial adhesion molecules . Blood. 1994; 84: 2068–2101 .
36.
Linker-Israeli M , Deans RJ , Wallace DJ et al. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis . J Immunol1991; 147: 117–123 .
37.
Sponk PE , ter Borg EJ , Limburg PC , Kallenberg CGM . Plasma concentrations of IL-6 in systemic lupus erythematosus: an indicator of disease activity?Clin Exp Immunol1992; 90: 106–110 .
38.
Crisp SJ , Dunn MJ , Rose ML et al. Antiendothelial antibodies after heart transplantation: the accelerating factor in transplant-associated coronary artery disease?J Heart Lung Transpl1994; 13: 81–91 .
39.
Dunn MJ , Crisp SJ , Rose ML et al. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation . Lancet1992; 339: 1566–1570 .
